Vivo Bio Tech Ltd

BSE: 511509

46

total announcements

VIVOBIOT.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 06 Nov 2026

Market Cap

₹33 Cr

EPS (TTM)

₹-1.43

52W Low

₹12.00

52W High

₹20.44

Dividend Yield

0.00%

Beta

0.40

Price / Book

0.3

Debt / Equity

72.3

Revenue (TTM)

₹55 Cr

Gross Margin

84.61%

Operating Margin

10.65%

BSECompany UpdateMgmt Change30 Sept 2026

VIVO BIO TECH LIMITED

VIVO BIO TECH LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

VIVO BIO TECH LIMITED has informed BSE about the re-appointment of an Executive Director.

BSECompany UpdateMgmt Change30 Sept 2026

VIVO BIO TECH LIMITED

VIVO BIO TECH LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

VIVO BIO TECH LIMITED has informed BSE about the re-appointment of an Executive Director.

BSECompany UpdateMgmt Change30 Sept 2026

VIVO BIO TECH LIMITED

VIVO BIO TECH LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

VIVO BIO TECH LIMITED has informed BSE about the re-appointment of an Executive Director.

BSECompany UpdateMgmt Change30 Sept 2026

VIVO BIO TECH LIMITED

VIVO BIO TECH LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

VIVO BIO TECH LIMITED has informed BSE about the re-appointment of an Executive Director.

BSECompany UpdateMgmt Change30 Sept 2026

VIVO BIO TECH LIMITED

VIVO BIO TECH LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

VIVO BIO TECH LIMITED has informed BSE about the re-appointment of an Executive Director.

BSECompany UpdateMgmt Change30 Sept 2026

VIVO BIO TECH LIMITED

VIVO BIO TECH LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

VIVO BIO TECH LIMITED has informed BSE about the re-appointment of an Executive Director.

BSECompany UpdateMgmt Change30 Sept 2026

VIVO BIO TECH LIMITED

VIVO BIO TECH LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

VIVO BIO TECH LIMITED has informed BSE about the re-appointment of an Executive Director.

BSECompany UpdateMgmt Change30 Sept 2026

VIVO BIO TECH LIMITED

VIVO BIO TECH LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

VIVO BIO TECH LIMITED has informed BSE about the re-appointment of an Executive Director.

BSECompany UpdateMgmt Change30 Sept 2026

VIVO BIO TECH LIMITED

VIVO BIO TECH LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

Vivo Bio Tech has informed about the re-appointment of an Executive Director.

BSECompany UpdateMgmt Change30 Sept 2026

VIVO BIO TECH LIMITED

VIVO BIO TECH LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

VIVO BIO TECH LIMITED has informed BSE about the re-appointment of an Executive Director.

BSECompany UpdateMgmt Change30 Sept 2026

VIVO BIO TECH LIMITED

VIVO BIO TECH LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" >&nbsp;</td><td class="TTRow_left"><b>&nbsp;Details</b></td></tr> <tr><td ....

VIVO BIO TECH LIMITED has informed BSE about the re-appointment of an Executive Director.

BSECompany UpdateMgmt Change30 Sept 2026

Vivo Bio Tech Ltd

Please find enclosed

Vivo Bio Tech Ltd held its 39th Annual General Meeting (AGM) on September 30, 2026, through video conferencing, with all directors present. The meeting approved the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and re-appointed three whole-time directors. The company also provided remote e-voting facility for the meeting.

Read more →📎 1 attachment
BSEAGM/EGM30 Sept 2026

Vivo Bio Tech Ltd

Please find enclosed 39th AGM proceedings

Vivo Bio Tech Ltd held its 39th AGM on September 30, 2026, through video conferencing. The meeting was attended by 67 members, including 66 public members and 1 promoter. The AGM transacted four items of business, including the adoption of audited financial statements, appointment of a director, and re-appointment of whole-time directors. Remote e-voting was provided for all items of business, and the voting results will be disseminated to stock exchanges and uploaded on the company's website.

Read more →📎 1 attachment
BSEInsider Trading / SASTResults25 Sept 2026

Vivo Bio Tech Ltd

Please find enclosed closure of trading window for quarter ended 30.09.2026

Vivo Bio Tech Ltd has announced the closure of its trading window for the quarter ended September 30, 2026, as per SEBI regulations and the company's internal code of conduct. The trading window will remain closed from October 1, 2026, until 48 hours after the declaration of the unaudited standalone and consolidated financial results for the second quarter.

Read more →📎 1 attachment
BSEGeneralResults8 Sept 2026

Vivo Bio Tech Ltd

Please find enclosed Annual report for FY 2025-26

Vivo Bio Tech Ltd has submitted its Annual Report for FY 2025-26, along with the Notice of 39th Annual General Meeting (AGM) scheduled for September 30, 2026. The report highlights key achievements, including GLP recognition for its canine facility, expansion of toxicology and analytical chemistry infrastructure, and strengthened CRO business.

Read more →📎 1 attachment
BSECompany Update24 Aug 2026

Vivo Bio Tech Ltd

Please find enclosed

Vivo Bio Tech Ltd has informed BSE that 6,27,409 convertible equity warrants issued to Dwight Technologies Private Limited have expired due to non-exercise before the completion of the tenure of eighteen months.

Read more →📎 1 attachment
BSEInsider Trading / SASTRelated Party24 Aug 2026

Vivo Bio Tech Ltd

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Maxcell Communication India Pvt Ltd

Vivo Bio Tech Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Maxcell Communication India Pvt Ltd, indicating a potential change in shareholding.

Read more →📎 1 attachment